{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:57:06Z","timestamp":1795064226908,"version":"4.10.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NCI"},{"name":"The South African Medical Research Council\/University of the Witwatersrand Common Epithelial Cancer Research Center"},{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer survival in South Africa is low, but when diagnosed with breast cancer, many women in South Africa also have other chronic conditions. We investigated the impact of multimorbidity (\u2265\u20092 other chronic conditions) on overall survival among women with breast cancer in South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 1 July 2015 and 31 December 2019, we enrolled women newly diagnosed with breast cancer at six public hospitals participating in the South African Breast Cancer and HIV Outcomes (SABCHO) Study. We examined seven chronic conditions (obesity, hypertension, diabetes, HIV, cerebrovascular diseases (CVD), asthma\/chronic obstructive pulmonary disease, and tuberculosis), and we compared socio-demographic, clinical, and treatment factors between patients with and without each condition, and with and without multimorbidity. We investigated the association of multimorbidity with overall survival using multivariable Cox proportional hazard models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 3,261 women included in the analysis, 45% had multimorbidity; obesity (53%), hypertension (41%), HIV (22%), and diabetes (13%) were the most common individual conditions. Women with multimorbidity had poorer overall survival at 3\u00a0years than women without multimorbidity in both the full cohort (60.8% vs. 64.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036) and stage groups: stages I\u2013II, 80.7% vs. 86.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), and stage III, 53.0% vs. 59.4% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024). In an adjusted model, women with diabetes (hazard ratio (HR)\u2009=\u20091.20, 95% confidence interval (CI)\u2009=\u20091.03\u20131.41), CVD (HR\u2009=\u20091.43, 95% CI\u2009=\u20091.17\u20131.76), HIV (HR\u2009=\u20091.21, 95% CI\u2009=\u20091.06\u20131.38), obesity\u2009+\u2009HIV (HR\u2009=\u20091.24 95% CI\u2009=\u20091.04\u20131.48), and multimorbidity (HR\u2009=\u20091.26, 95% CI\u2009=\u20091.13\u20131.40) had poorer overall survival than women without these conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Irrespective of the stage, multimorbidity at breast cancer diagnosis was an important prognostic factor for survival in our SABCHO cohort. The high prevalence of multimorbidity in our cohort calls for more comprehensive care to improve outcomes for South African women with breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-023-01603-w","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:03:03Z","timestamp":1674468183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study"],"prefix":"10.1186","volume":"25","author":[{"given":"Oluwatosin A.","family":"Ayeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witness","family":"Mapanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong Carl","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Phakathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Buccimazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"\u010ca\u010dala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura W.","family":"Stopforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Crew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duvern","family":"Ramiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Cubasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Chirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Micklesfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane A.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"key":"1603_CR2","unstructured":"South African National Cancer Registry: Cancer in South Africa. 2016."},{"key":"1603_CR3","unstructured":"Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z. SEER cancer statistics review, 1975\u20132012. Bethesda, MD: National Cancer Institute 2015, 2015."},{"issue":"9","key":"1603_CR4","doi-asserted-by":"publisher","first-page":"e1203","DOI":"10.1016\/S2214-109X(20)30261-8","volume":"8","author":"V McCormack","year":"2020","unstructured":"McCormack V, McKenzie F, Foerster M, Zietsman A, Galukande M, Adisa C, Anele A, Parham G, Pinder LF, Cubasch H. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020;8(9):e1203\u201312. https:\/\/doi.org\/10.1016\/S2214-109X(20)30261-8.","journal-title":"Lancet Glob Health"},{"key":"1603_CR5","doi-asserted-by":"publisher","unstructured":"Brettschneider C, Leicht H, Bickel H, Dahlhaus A, Fuchs A, Gensichen J, Maier W, Riedel-Heller S, Sch\u00e4fer I, Sch\u00f6n G. Relative impact of multimorbid chronic conditions on health-related quality of life\u2013results from the MultiCare Cohort Study. PLoS ONE 2013;8(6):e66742. https:\/\/doi.org\/10.1371\/journal.pone.0066742","DOI":"10.1371\/journal.pone.0066742"},{"issue":"9836","key":"1603_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2.","journal-title":"The Lancet"},{"issue":"1","key":"1603_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41562-021-01242-1","volume":"6","author":"E Mendenhall","year":"2022","unstructured":"Mendenhall E, Kim AW, Panasci A, Cele L, Mpondo F, Bosire EN, Norris SA, Tsai AC. A mixed-methods, population-based study of a syndemic in Soweto, South Africa. Nat Hum Behav. 2022;6(1):64\u201373. https:\/\/doi.org\/10.1038\/s41562-021-01242-1.","journal-title":"Nat Hum Behav"},{"issue":"10072","key":"1603_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0140-6736(17)30003-X","volume":"389","author":"M Singer","year":"2017","unstructured":"Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. The Lancet. 2017;389(10072):941\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(17)30003-X.","journal-title":"The Lancet"},{"issue":"4","key":"1603_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"issue":"1","key":"1603_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Prev Biomark. 2016;25(1):16\u201327. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0578.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"10134","key":"1603_CR11","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0140-6736(18)30665-2","volume":"391","author":"MY Bertram","year":"2018","unstructured":"Bertram MY, Sweeny K, Lauer JA, Chisholm D, Sheehan P, Rasmussen B, Upreti SR, Dixit LP, George K, Deane S. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services. The Lancet. 2018;391(10134):2071\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(18)30665-2.","journal-title":"The Lancet"},{"issue":"2","key":"1603_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ijc.32727","volume":"147","author":"OA Ayeni","year":"2020","unstructured":"Ayeni OA, Norris SA, Joffe M, Cubasch H, Nietz S, Buccimazza I, Singh U, \u010ca\u010dala S, Stopforth L, Chen WC. The multimorbidity profile of South African women newly diagnosed with breast cancer. Int J Cancer. 2020;147(2):361\u201374. https:\/\/doi.org\/10.1002\/ijc.32727.","journal-title":"Int J Cancer"},{"issue":"1","key":"1603_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/0284186X.2017.1407496","volume":"57","author":"M Ewertz","year":"2018","unstructured":"Ewertz M, Land LH, Dalton SO, Cronin-Fenton D, Jensen M-B. Influence of specific comorbidities on survival after early-stage breast cancer. Acta Oncol. 2018;57(1):129\u201334. https:\/\/doi.org\/10.1080\/0284186X.2017.1407496.","journal-title":"Acta Oncol"},{"issue":"2","key":"1603_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.soncn.2015.02.004","volume":"31","author":"K Meneses","year":"2015","unstructured":"Meneses K, Benz R, Azuero A, Jablonski-Jaudon R, McNees P. Multimorbidity and Breast Cancer. Semin Oncol Nurs. 2015;31(2):163\u20139. https:\/\/doi.org\/10.1016\/j.soncn.2015.02.004.","journal-title":"Semin Oncol Nurs"},{"key":"1603_CR15","doi-asserted-by":"publisher","unstructured":"Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ, Guicherit OR, Merkus JW, Extermann M, van de Velde CJ, Liefers G-J. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Res Treat 2014;145(1):185\u2013192. https:\/\/doi.org\/10.1007\/s10549-014-2917-7","DOI":"10.1007\/s10549-014-2917-7"},{"issue":"9","key":"1603_CR16","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/ijc.33387","volume":"148","author":"OA Ayeni","year":"2021","unstructured":"Ayeni OA, Norris SA, Joffe M, Cubasch H, Galukande M, Zietsman A, Parham G, Adisa C, Anele A, Sch\u00fcz J. Preexisting morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African Breast Cancer\u2014disparities in Outcomes study. Int J Cancer. 2021;148(9):2158\u201370. https:\/\/doi.org\/10.1002\/ijc.33387.","journal-title":"Int J Cancer"},{"issue":"2","key":"1603_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1200\/JGO.2015.002675","volume":"3","author":"H Cubasch","year":"2017","unstructured":"Cubasch H, Ruff P, Joffe M, Norris S, Chirwa T, Nietz S, Sharma V, Duarte R, Buccimazza I, \u010ca\u010dala S. South African breast cancer and HIV outcomes study: methods and baseline assessment. J Glob Oncol. 2017;3(2):114\u201324. https:\/\/doi.org\/10.1200\/JGO.2015.002675.","journal-title":"J Glob Oncol"},{"key":"1603_CR18","doi-asserted-by":"publisher","unstructured":"Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17(6):1471\u20131474. https:\/\/doi.org\/10.1245\/s10434-010-0985-4","DOI":"10.1245\/s10434-010-0985-4"},{"issue":"15","key":"1603_CR19","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","volume":"25","author":"CA Hudis","year":"2007","unstructured":"Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman J-AW, Sparano JA, Hunsberger S, Enos RA, Gelber RD. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol. 2007;25(15):2127\u201332. https:\/\/doi.org\/10.1200\/JCO.2006.10.3523.","journal-title":"J Clin Oncol"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canep.2017.05.010","volume":"49","author":"O Par\u00e9s-Badell","year":"2017","unstructured":"Par\u00e9s-Badell O, Banqu\u00e9 M, Maci\u00e0 F, Castells X, Sala M. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000\u20132014). Cancer Epidemiol. 2017;49:66\u201374. https:\/\/doi.org\/10.1016\/j.canep.2017.05.010.","journal-title":"Cancer Epidemiol"},{"key":"1603_CR21","doi-asserted-by":"publisher","unstructured":"Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA 2016;66(4):337\u2013350. https:\/\/doi.org\/10.3322\/caac.21342","DOI":"10.3322\/caac.21342"},{"key":"1603_CR22","doi-asserted-by":"publisher","unstructured":"Willadsen TG, Siersma V, Nicolaisd\u00f3ttir DR, K\u00f8ster-Rasmussen R, Jarb\u00f8l DE, Reventlow S, Mercer SW, Olivarius NdF. Multimorbidity and mortality: a 15-year longitudinal registry-based nationwide Danish population study. J Comorb 2018;8(1):2235042X18804063\u201312235042X18804063. https:\/\/doi.org\/10.1177\/2235042X18804063","DOI":"10.1177\/2235042X18804063"},{"key":"1603_CR23","doi-asserted-by":"publisher","unstructured":"Wade AN, Payne CF, Berkman L, Chang A, G\u00f3mez-Oliv\u00e9 FX, Kabudula C, Kahn K, Salomon JA, Tollman S, Witham M. Multimorbidity and mortality in an older, rural black South African population cohort with high prevalence of HIV findings from the HAALSI Study. BMJ Open 2021;11(9):e047777. https:\/\/doi.org\/10.1136\/bmjopen-2020-047777","DOI":"10.1136\/bmjopen-2020-047777"},{"issue":"3","key":"1603_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jgo.2011.02.004","volume":"2","author":"SM Koroukian","year":"2011","unstructured":"Koroukian SM, Bakaki PM, Schluchter MD, Owusu C. Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer. J Geriatr Oncol. 2011;2(3):200\u20138. https:\/\/doi.org\/10.1016\/j.jgo.2011.02.004.","journal-title":"J Geriatr Oncol"},{"issue":"2","key":"1603_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.critrevonc.2011.03.001","volume":"81","author":"LH Land","year":"2012","unstructured":"Land LH, Dalton SO, J\u00f8rgensen TL, Ewertz M. Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol\/Hematol. 2012;81(2):196\u2013205. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.03.001.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"1603_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2010.31.3049","volume":"29","author":"L Lee","year":"2011","unstructured":"Lee L, Cheung WY, Atkinson E, Krzyzanowska MK. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2011;29(1):106\u201317. https:\/\/doi.org\/10.1200\/JCO.2010.31.3049.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1603_CR27","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/cncr.21934","volume":"106","author":"AJCM Vulto","year":"2006","unstructured":"Vulto AJCM, Lemmens VEPP, Louwman MWJ, Janssen-Heijnen MLG, Poortmans PHP, Lybeert MLM, Coebergh JWW. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer. 2006;106(12):2734\u201342. https:\/\/doi.org\/10.1002\/cncr.21934.","journal-title":"Cancer"},{"issue":"3","key":"1603_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1523-5394.2000.83004.x","volume":"8","author":"JS Kutner","year":"2000","unstructured":"Kutner JS, Vu KO, Prindiville SA, Byers TE. Patient age and cancer treatment decisions: patient and physician views. Cancer Pract. 2000;8(3):114\u20139. https:\/\/doi.org\/10.1046\/j.1523-5394.2000.83004.x.","journal-title":"Cancer Pract"},{"key":"1603_CR29","doi-asserted-by":"publisher","unstructured":"Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. JNCI 1993;85(19):1580\u20131584. https:\/\/doi.org\/10.1093\/jnci\/85.19.1580","DOI":"10.1093\/jnci\/85.19.1580"},{"key":"1603_CR30","doi-asserted-by":"publisher","unstructured":"Bibi R, Azhar S, Iqbal A, Jabeen H, Kalsoom U-e, Iqbal MM, Nazeer M. Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors. J Oncol Pharm Pract 2020;27(7):1616\u20131622. https:\/\/doi.org\/10.1177\/1078155220963212","DOI":"10.1177\/1078155220963212"},{"key":"1603_CR31","doi-asserted-by":"publisher","unstructured":"Ording AG, Garne JP, Nystr\u00f6m PMW, Fr\u00f8slev T, S\u00f8rensen HT, Lash TL. Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis\u2014a Danish nationwide matched cohort study. PLoS ONE 2013;8(10):e76013. https:\/\/doi.org\/10.1371\/journal.pone.0076013","DOI":"10.1371\/journal.pone.0076013"},{"issue":"9","key":"1603_CR32","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA. Annual Report to the Nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290\u2013314. https:\/\/doi.org\/10.1002\/cncr.28509.","journal-title":"Cancer"},{"key":"1603_CR33","doi-asserted-by":"publisher","unstructured":"Kendal WS. Dying with cancer: the influence of age, comorbidity, and cancer site. Cancer 2008;112(6):1354\u20131362. https:\/\/doi.org\/10.1002\/cncr.23315","DOI":"10.1002\/cncr.23315"},{"issue":"1","key":"1603_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-013-2521-2","volume":"139","author":"S Nechuta","year":"2013","unstructured":"Nechuta S, Lu W, Zheng Y, Cai H, Bao P-P, Gu K, Zheng W, Shu XO. Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat. 2013;139(1):227\u201335. https:\/\/doi.org\/10.1007\/s10549-013-2521-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"1603_CR35","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1002\/cncr.32158","volume":"125","author":"AE Coghill","year":"2019","unstructured":"Coghill AE, Han X, Suneja G, Lin CC, Jemal A, Shiels MS. Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base. Cancer. 2019;125(16):2868\u201376. https:\/\/doi.org\/10.1002\/cncr.32158.","journal-title":"Cancer"},{"issue":"21","key":"1603_CR36","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","volume":"33","author":"AE Coghill","year":"2015","unstructured":"Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33(21):2376. https:\/\/doi.org\/10.1200\/JCO.2014.59.5967.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1603_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ijc.33981","volume":"151","author":"OA Ayeni","year":"2022","unstructured":"Ayeni OA, O\u2019Neil DS, Pumpalova YS, Chen WC, Nietz S, Phakathi B, Buccimazza I, \u010ca\u010dala S, Stopforth LW, Farrow HA. Impact of HIV infection on Survival among Women with Stage I-III Breast Cancer: Results from the South African Breast Cancer and HIV Outcomes Study. Int J Cancer. 2022;151(2):209\u201321. https:\/\/doi.org\/10.1002\/ijc.33981.","journal-title":"Int J Cancer"},{"issue":"10072","key":"1603_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(17)30402-6","volume":"389","author":"E Mendenhall","year":"2017","unstructured":"Mendenhall E. Syndemics: a new path for global health research. The Lancet. 2017;389(10072):889\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(17)30402-6.","journal-title":"The Lancet"},{"issue":"10072","key":"1603_CR39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(17)30402-6","volume":"389","author":"E Mendenhall","year":"2017","unstructured":"Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet. 2017;389(10072):951\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(17)30402-6.","journal-title":"Lancet"},{"issue":"6","key":"1603_CR40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/inthealth\/ihv040","volume":"7","author":"T Oni","year":"2015","unstructured":"Oni T, Unwin N. Why the communicable\/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health. 2015;7(6):390\u20139. https:\/\/doi.org\/10.1093\/inthealth\/ihv040.","journal-title":"Int Health"},{"key":"1603_CR41","unstructured":"Baciu A, Negussie Y, Geller A, Weinstein JN, National Academies of Sciences E, Medicine. The root causes of health inequity. In: Communities in action: pathways to health equity. edn.: National Academies Press (US);2017."},{"key":"1603_CR42","unstructured":"Marquez P, Farrington J. Ending the communicable and non-communicable diseases divide in Africa. Africa can end Poverty blog(blogs worldbank org\/africacan\/ending-the-communicable-and-non-communicable-dis). Last accessed on 2012 Oct 07;2012."},{"issue":"9729","key":"1603_CR43","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","volume":"375","author":"AD Harries","year":"2010","unstructured":"Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM. The HIV-associated tuberculosis epidemic\u2014When will we act? The Lancet. 2010;375(9729):1906\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(10)60409-6.","journal-title":"The Lancet"},{"issue":"5","key":"1603_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/thoraxjnl-2013-204460","volume":"69","author":"P Burney","year":"2014","unstructured":"Burney P, Jithoo A, Kato B, Janson C, Mannino D, Ni\u017cankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Ko\u00e7abas A, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty\u2014a BOLD analysis. Thorax. 2014;69(5):465. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204460.","journal-title":"Thorax"},{"key":"1603_CR45","doi-asserted-by":"publisher","unstructured":"Kandala NB, Nnanatu CC, Dukhi N, Sewpaul R, Davids A, Reddy SP. Mapping the burden of hypertension in South Africa: a comparative analysis of the national 2012 SANHANES and the 2016 Demographic and Health Survey. Int J Environ Res Public Health 2021;18(10). https:\/\/doi.org\/10.3390\/ijerph18105445","DOI":"10.3390\/ijerph18105445"},{"issue":"8","key":"1603_CR46","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30\u201366. https:\/\/doi.org\/10.1161\/CIR.0000000000000556.","journal-title":"Circulation"},{"issue":"2","key":"1603_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10552-012-0115-7","volume":"24","author":"A Kamineni","year":"2013","unstructured":"Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes Control. 2013;24(2):305\u201312. https:\/\/doi.org\/10.1007\/s10552-012-0115-7.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1603_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10552-016-0837-z","volume":"28","author":"M Charlot","year":"2017","unstructured":"Charlot M, Castro-Webb N, Bethea TN, Bertrand K, Boggs DA, Denis GV, Adams-Campbell LL, Rosenberg L, Palmer JR. Diabetes and breast cancer mortality in Black women. Cancer Causes Control. 2017;28(1):61\u20137. https:\/\/doi.org\/10.1007\/s10552-016-0837-z.","journal-title":"Cancer Causes Control"},{"key":"1603_CR49","first-page":"10","volume":"55","author":"P Reddy","year":"2017","unstructured":"Reddy P, Ebrahim S, Singh B, Ramklass S, Buccimazza I. Breast Cancer and HIV: a South African perspective and a critical review of the literature. S Afr J Surg. 2017;55:10\u20135.","journal-title":"S Afr J Surg"},{"issue":"4","key":"1603_CR50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7196\/SAMJ.2019.v109i4.13465","volume":"109","author":"O Ayeni","year":"2019","unstructured":"Ayeni O, Joffe M, Cubasch H, Rinaldi S, Taljaard C, Vorster E, Romieu I, Norris S. Prevalence of comorbidities in women with and without breast cancer in Soweto, South Africa: Results from the SABC study. S Afr Med J. 2019;109(4):264\u201371. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i4.13465.","journal-title":"S Afr Med J"}],"updated-by":[{"DOI":"10.1186\/s13058-023-01611-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000}}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-023-01603-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:45:26Z","timestamp":1720694726000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1186\/s13058-023-01603-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1583980\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"22 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13058-023-01611-w","URL":"https:\/\/doi.org\/10.1186\/s13058-023-01611-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SABCHO Study was approved by the University of the Witwatersrand Human Research Ethics Committee (Approval Number: Ml50351, dated: 6th May 2015, recertified M1911203 dated 28 January 2020), the University of KwaZulu-Natal Biomedical Research Committee, BF080\/15, and the Institutional Review Board of Columbia University (protocol number AAAQ1359, dated 1st January 2016). All women provided written or fingerprint-confirmed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AIN has consulted for Otsuka, Eisai, GlaxoSmithKline, United Biosource Corp., and Hospira. He has grant support from Otsuka. He is on the medical advisory board of EHE Intl. All other authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}